Decoction Research Articles

Network pharmacological analysis and mechanism prediction of Xiaochaihu Decoction in treatment of COVID-19 with syndrome of pathogenic heat lingering in lung and obstructive cardinalate

Network pharmacological analysis and mechanism prediction of Xiaochaihu Decoction in treatment of COVID-19 with syndrome of pathogenic heat lingering in lung and obstructive cardinalate

Drug-induced liver injury: an analysis of 384 cases

Objective To analyze the causes, clinical characteristics and treatment outcomes of drug-induced liver injury (DILI). Methods The general information, medication history, clinical classification, grade of liver injury and clinical outcome of 384 patients with drug-induced liver injury admitted in Changjiang River Hospital during January 2014 to December 2018 were retrospectively analyzed. Results Among 384 cases of drug-induced liver injury, there were 191 cases aged ≥60 (49.7%). The top three drugs inducing liver injury were antibiotics, anti-tuberculosis drugs and immune-enhancing Traditional Chinese Medicine (TCM) decoction, accounting for 40.6%(156/384), 20.3%(78/384)and 15.6% (60/384), respectively. In 60 cases of TCM decoction-induced liver injury, 39 cases were cholestatic liver injury (65.0%,39/60), 11 cases were hepatocellular liver injury (18.3%,11/60) and 10 were mixed liver injury (16.7%,10/60) (χ2=40.650, P<0.01). In 44 cases of DILI caused by anti-cancer chemotherapeutic drugs, 25 cases were hepatocellular liver injury (56.8%,25/44), 12 cases were cholestatic liver injury (27.3%,12/44) and 7 cases were mixed liver injury (15.9%,7/44) (χ2=17.659, P<0.01). The proportion of treatment failure in patients with grade 4 liver injury was 5/10 and the proportion of mortality in patients with grade 5 liver injury was 8/8, which were significantly higher than those with lower grade liver injury (χ2=157.218, P<0.01; χ2=320.917, P<0.01). Conclusion The development of drug-induced liver injury and its clinical classification are related to the types of drug, and the prognosis of drug-induced liver injury is depended on the degree of liver injury. Key words: Drug-induced liver injury; Anti-bacterial agents; Antitubercular agents; Drugs, Chinese herbal

The mechanism of Huanglian-Ejiao Decoction in the treatment of insomnia based on network pharmacology

Objective By taking network pharmacology approach to search for active components and the rapeutic targets of Huanglian-Ejiao Decoction. Methods According to the pharmacokinetic parameters, this research screened components of this decoction, and diged the drugs and disease targets with network pharmacology and constructed the drug-target-pathway network by Cytoscape system to investigate the mechanism of Huanglian-Ejiao Decoction. Results It was found that 19 components such as hydroberberine, β-sitosterol, curcumin, kaempferol, berberine and Ramie flavonoids in Huanglian-Ejiao Decoction could take effecton insomnia by regulating 25 targets such as 5-hydroxytryptamine, dopamine, gamma aminobutyric acid, opioid receptor and acetylcholine. Conclusion Huanglian-Ejiao Decoction may play an important role in treating insomnia by regulating multiple-targets. Key words: Huang Lian E Jiao Tang; Insomnia; Network pharmacology; Gamma-aminobutyric acid receptor; 5-hydroxytryptamine receptor

Clinical research on Qianghuo Decoction iontophoresis combined with joint mobilization technique in treating knee osteoarthritis patients with cold-damp syndromea

Objective To investigate the effect of Qianghuo Decoction iontophoresis combined with joint mobilization technique in treating Knee Osteoarthritis (KOA) patients with cold-damp syndrome. Methods A total of 98 KOA patients, who were admitted in our hospital from October 2017 to October 2018, were randomly divided into control group and observation group (49 in each group) according to random number table method. Both groups were treated by joint mobilization technique. The control group were given Glucosamine sulfate capsule (0.5 g/time and tid) orally. The observation group was treated by iontophoresis of Qianghuo Decoction. After 6 weeks’ treatment, to evaluate syndrome of cold-damp, the efficacy, by using bone metabolism indexes, the Western Ontario and McMaster Universities (WOMAC) and symptoms of such as serum levels of collagen type Ⅱ C-peptide (CTX-Ⅱ), collagen type Ⅰ C-peptide (CTX-Ⅰ), tartrate-resistant acid phosphatase isoform 5b (TRACP-5b), and the pain medium indexes, such as serum levels of prostaglandin E2 (PGE2), substance P (SP), dopamine (DA), 5-hydroxytryptamine (5-HT) were compared between two groups. Results After the treatment, the total efficacy in the observation group was 93.9% (46/49), the control group was 77.6% (38/49), and the difference between the two groups was statistically significant (χ2=4.083, P=0.043). After the treatment, scores of WOMAC indexes joint pain, joint stiffness, limited daily movement of the observation group were significantly lower than those of the control group (t values 8.430, 9.986, 12.776, respectively, all Ps<0.01), and scores of symptoms joint pain, joint temperature pain reduction, morning stiffness, waist pain of the observation group were significantly lower than those of the control group (t values 8.825, 9.043, 7.230, 7.034, respectively, all Ps <0.01). After treatment, the serum levels of CTX-Ⅰ (404.99 ± 43.35 g/L vs. 458.69 ± 48.61 g/L, t=21.005), CTX-Ⅱ (414.99 ± 43.39 g/L vs. 484.06 ± 50.77 g/L, t=18.991), TRACP-5b (2.98 ± 0.35 U/L vs. 5.67 ± 0.61 U/L, t=9.043) of the observation group were significantly lower than those of the control group (P<0.01); while the serum levels of PGE2 (167.81 ± 18.79 g/L vs. 252.61 ± 27.34 g/L, t=26.389), SP (143.67 ± 15.92 g/L vs. 179.55 ± 19.53 g/L, t=25.416), DA (9.15 ± 1.15 g/L vs. 13.17 ± 1.81 g/L, t=10.445), 5-HT (615.08 ± 63.95 g/L vs. 712.69 ± 72.88 g/L, t=31.004) were significantly lower than those of the control group (P<0.01). Conclusions Iontophoresis of Qianghuo Decoction combined with joint mobilization technique for KOA patients with syndrome of cold-damp can improve the symptoms of the patients, reduce the level of bone metabolism, reduce the pain mediators, improve clinical symptoms and enhance efficacy. Key words: Osteoarthritis, knee; Qianghuo Decoction; Penetration of ions; Joint mobilization technique; Cold dampness blocking collaterals; Syndrome differentiation classification

Efficacy and mechanism of Xiaobanxia Decoction and categorized formula in preventing and treating delayed chemotherapeutic vomiting

Objective To observe the pharmacodynamic effect of Xiaobanxia Decoction (XBXD) and categorized formula on cisplatin-induced delayed chemotherapeutic vomiting in rats, and to explore its prevention and treatment mechanism. Methods Sixty Wistar rats were randomly divided into blank group, model group, ondansetron group, XBXD group, Ginger Pinellia Decoction group and Pinellia and Dried Ginger Powder group, with 10 rats in each group. The ondansetron group was given 2.6 mg/(kg•d) ondansetron, the XBXD group was given XBXD 22 g/(kg•d), the Ginger Pinellia Decoction group was given 31.5 ml/(kg•d) Ginger Pinellia Decoction, and Pinellia and Dried Ginger Powder group was given 0.63 g/(kg•d) Dried Ginger Powder. The blank group and the model group were intragastrically administered with normal saline. All the treattmens were last for three days and twice per day. After the first administration, except the blank group, the rats in all groups were intraperitoneally injected with 6 mg/kg cisplatin to establish chemotherapy-induced vomiting model. The kaolin intake of the chemotherapical rats were weighed every 24 h, and the ileum and medulla 5-HT, 5-HIAA, TPH and MAOA levels were detected by ELISA. Results Compared with the model group, the kaolin intake of the chemotherapy rats in each treatment group significantly decreased (P<0.05). The levels of ileum 5-HT (308.04 ± 29.90 ng/L, 355.97 ± 19.16 ng/L, 389.97 ± 24.86 ng/L vs. 498.95 ± 13.92 ng/L) and medulla 5-HT (375.32 ± 19.33 ng/L, 395.18 ± 16.12 ng/L, 406.68 ± 12.09 ng/L vs. 478.52 ± 13.88 ng/L) in the XBXD group, Ginger Pinellia Decoction group and Pinellia and Dried Ginger Powder significantly decreased (P<0.05). The levels of ileum TPH (35.14 ± 2.68 ng/L vs. 47.31 ± 0.83 ng/L) in the XBXD group significantly decreased (P<0.05). The levels of medulla TPH (33.68 ± 2.79 ng/L, 38.19 ± 1.74 ng/L vs. 43.68 ± 1.53 ng/L) in the Ginger Pinellia Decoction group and Pinellia and Dried Ginger Powder significantly decreased (P<0.05). The levels of MAOA, 5-HIAA in the ileum and medulla of the XBXD group, Ginger Pinellia Decoction group and Pinellia and Dried Ginger Powder significantly decreased (P<0.05). Conclusions XBXD and categorized formula can effectively prevent and treat delayed chemotherapy-induced vomiting in rats, and its mechanism may be related to decrease the TPH level and inhibiting 5-HT synthesis. Key words: Xiao Ban Xia Tang; Chemotherapy-induced vomiting; 5-hydroxytryptamine; Tryptophan hydroxylase; Rats

Clinical study of fumigation with Shujin-Jieluan Decoction combined with Pingheng-Shujin Manipulation in the treatment of chirospasm after stroke

Objective To evaluate the efficacy of fumigation with Shujin-Jieluan Decoction combined with Pingheng-Shujin Manipulation (manipulation of balance and muscle tendon relaxing) in the treatment of chirospasm after stroke. Methods A total of 104 patients with chirospasm after stroke who metthe inclusion criteria from July 2016 to June 2018 were selectedand divided into tow groups with the digital table methodwith 52 cases in each group. The control group was given routine rehabilitation training while the observation group was given fumigation with Shujin-Jieluan decoction combined with Pingheng-Shujin manipulation based oncontrol group, and the two groups both were treated for 8 weeks. The Modified Ashworth Scale (MAS) was used for chirospasm classification, and Key Point tabletop electromyography device was used to record the frequency, average amplitude and the shortest latency of F wave of median nerve. Fugl-Meyer motor function rating scale was used to evaluate hand motor function, and modified Barthel Index (BI) was used to evaluate life functionand clinical efficacy. Results The effective rate was 88.5% (46/52) in observation group and was 65.4% (34/52) in control group (χ2=7.800, P=0.005). After treatment, the frequency (15.11 ± 2.06 vs. 16.72 ± 1.95, t=4.093), average amplitude (0.52 ± 0.04 mV vs. 0.59 ± 0.05 mV, t=7.883) and the shortest latency (24.37 ± 2.85 ms vs. 25.88 ± 2.43 ms, t=2.907) of F wave in observation group were significantly lower than the control group (P<0.01). Fugl-Meyer hand function score (6.51 ± 1.45 vs. 5.09 ± 1.22, t=5.404) and BI index score (60.87 ± 5.16 vs. 56.54 ± 4.25, t=4.671) were significantly higher than the control group (P<0.01). The distribution of MAS classification in observation group was significantly lower than that of control group (Z=8.410, P=0.004). Conclusions Fumigation with Shujin-Jieluan Decoction combined with Pingheng-Shujin Manipulation can improve the neuromuscular transmission of patients with chirospasm after stroke, and facilitate the recovery of hand function and viability. Key words: Stroke; Spasm; Rehabilitation of traditional Chinese medicine; Shujin-Jieluan Decoction; Muscle tendon relaxing reduction; Steaming washing therapy

Effect of Qishen-Xiaodian Decoction combined with laser acupoint irradiation on recurrence oxidative stress and renal function oin children with henoch schonlein purpura

Objective To explore the effect of Qishen-Xiaodian Decoction combined with laser acupoint irradiation on oxidative stress and renal function on children with recurrent henoch schonlein purpura (HSP). Methods A total of 120 children with recurrent HSP in the dermatology department clinic of Hospital of Xinle City from January 2015 to November 2017 were divided into two groups according to the random number table method, with 60 cases in each group. The control group took loratadine, Troxerutin and vitamin C orally, while the treatment group took Chinese medicine combined with laser acupoint irradiation based onthe control group. Drugs were taken orally for 4 weeks, laser acupoint irradiation treatment for 2 weeks. The level of glutathione peroxidase (GSH-Px) in plasma was detected by ELISA, the levels of MDA and SOD in plasma were detected by thiobarbituric acid colorimetry and hydroxylamine method, the level of IgG, micro albumin (Alb), β2-microglobulin (β2-MG) in urine were detected by radioimmunoassay, and the clinical effect was evaluated. The recurrence was recorded. Results After treatment, the plasma GSH-Px (90.45 ± 15.36 μmol/L vs. 81.62 ± 13.68 μmol/L, t=3.318), SOD (99.64 ± 18.66 IU/ml vs. 84.21 ± 16.73 IU/ml, t=4.769) in the treatment group were significantly higher than the control group (P<0.01); the MDA (5.58 ± 1.31 μmol/L vs. 4.37 ± 1.36 μmol/L, t=4.964) was significantly lower than the control group (P<0.01); the ratio of urine IgG (3.48 ± 0.95 mg/L vs. 6.56 ± 1.47 mg/L, t=13.630), Alb (7.80 ± 2.94 mg/L vs. 12.73 ± 4.26 mg/L, t=7.378), β2-MG (4.02 ± 1.61 mg/L vs. 6.95 ± 2.10 mg/L, t=8.577) were significantly lower than those of the control group (P<0.01). The total effective rate was 95.0% (57/60) in the treatment group and 80.0% (48/60) in the control group. There was statistically significant difference between two groups (χ2=6.171, P=0.013). Follow-up of 6 and 12 months, the recurrence rate of the treatment group were significantly lower than that of the control group (χ2 value were 4.931, 4.574, P<0.05). Conclusions Qishen-Xiaodian Decoction combined with laser acupoint irradiation can improve the oxidative stress of children with recurrent HSP, protect the renal function, improve the clinical efficacy and reduce the recurrence rate. Key words: Purpura, schoenlein-henoch; Recurrence; Qishen-Xiaodian Decoction; Lasers, semiconductor; Oxidative stress; Kidney function tests

Short-term curative effect of Buqi Yishen decoction combined with chemotherapy in the treatment of patients with colorectal cancer and its influence on immune function and tumor markers

目的 探讨补肾益气方联合化疗治疗结直肠癌的近期疗效及对患者免疫功能、肿瘤标志物的影响。 方法 选择嘉兴市第二医院2017年1月至2019年1月收治的结直肠癌患者102例为研究对象，采用随机数字表法分为观察组51例与对照组51例。对照组患者予化疗治疗，观察组在对照组基础上联合补气益肾方治疗。两组均以21 d为1个疗程，共3个疗程。比较两组近期疗效，治疗前后卡氏功能状态量表(KPS)评分、免疫功能和肿瘤标志物变化及不良反应发生情况。 结果 观察组近期总有效率(76.47%)高于对照组(54.90%)(χ2＝5.263，P<0.05)；观察组治疗后KPS评分[(86.54±5.28)分]高于对照组[(78.98±5.32)分](t＝7.203，P<0.05)。观察组治疗后CD3＋[(63.28±5.64%)]、CD4＋[(39.82±4.21%)]和CD4＋/CD8＋[(1.67±0.23)]均高于对照组[(46.71±4.25%)、(29.34±2.43%)和(0.86±0.14)](t＝16.756、15.397、21.483，均P<0.05)。观察组治疗后癌胚抗原(CEA)[(8.98±1.89)μg/L]和糖类抗原724(CA724)[(7.98±1.74)μg/L]均低于对照组[(15.79±2.54)μg/L和(14.19±2.09)μg/L](t＝15.361、16.308，均P<0.05)。观察组血小板减少(13.73%)、白细胞减少(11.76%)、肝肾异常(7.84%)、胃肠道反应(15.09%)和乏力(13.73%)均低于对照组(35.29%、29.41%、27.45%、49.02%和37.25%)(χ2＝6.411、4.875、6.746、12.946、7.433，均P<0.05)。 结论 补气益肾方联合化疗对结直肠癌患者近期疗效明显，可增强机体免疫功能，降低血清CEA和CA724水平，不良反应少。

The parametric measurementof physico-chemical parameter and three types of effective components in Jiedu-Zhixue Decoction

Objective To set up a method to measure the content of baicaline, wogonoside, and paeonol in Jiedu-Zhixue Decoction extract and to measure their physico-chemical parameters. Methods By using HPLC analytical methods to measure the content of baicaline, wogonoside, and paeonol in Jiedu-Zhixue Decoction extract. The RP18 column was adopted, gradient eluted with mobile phase of acetonitrile-1% phosphoric acid water, flow rate was 1 ml/min, detection wavelength was 274 nm, and the column temperature was 30 ℃. The method quantitatively analyze the compound extracts of baicaline, wogonoside and paeonol were used. Results The method isrepeatable, stable with good recorey rates. The calibration curves of baicaline was in good linearity over the range of 0.191 2-1.147 2 μg. The calibration curves of wogonoside was in good linearity over the range of 0.041 5-0.207 4 μg. The calibration curves of paeonol was in good linearity over the range of 0.019 5-0.156 3 μg. There was no significant difference among the component of 3 different batches of Jiedu-Zhixue Decoction extract, and the pH value range was 5.240-5.753, relative density range was 0.846-0.889. Conclusions The method used in this stydy to measure the effective components of Jiedu-Zhixue Decoction extract was stable and feasible, which is suitable for quality control of Jiedu-Zhixue Decoction. Key words: Dosage forms improving; Jiedu-Zhixue Decoction; Baicaline; Wogonoside; Paeonol; Physico-chemical parameter; High performance liquid chromatography; Quality control

Microscopical spermatic vein ligation combined with shaofu zhuyu decoction for the treatment of varicocele caused by sthenospermia

Objective To investigate the clinical effect of varicocele(VC) induced oligospermia treated by arterial microvascularization combined with shaofu zhuyu decoction. Methods From March 2016 to October 2018, 50 cases of VC infertility patients were seleced and randomly divided into treatment group and the control group(n=25), the treatment group were given by microscopic spermatic vein ligation combined lower abdomen stasis soup, one dose a day, morning and evening for three months. In the control group, only microscopical spermatic vein ligation was performed. Results All the patients were successfully operated, the postoperative symptoms disappeared, the sperm concentration, semen volume and sperm activity were significantly increased, and the percentage of abnormal sperm was significantly decreased, the difference was statistically significant(P<0.05). The semen parameters of the patients in the treatment group with shaofu zhuyu decoction improved significantly after 3 months, there was significantly better than the control group. Conclusions Microscopical spermatic vein ligation combined with shaofu zhuyu decoction for the treatment of asthenospermia caused by varicocele has a satisfactory effect and the semen quality has been improved obviously. Key words: Varicocele; Asthenozoospermia; Ligation; CHINESE PATENT DRUGS

Clinical effect of Huoxue Qing Gong decoction in the treatment of vaginal bleeding after medical abortion

Objective To explore the clinical effect of Huoxue Qing Gong decoction in the treatment of vaginal bleeding after medical abortion. Methods From May 2016 to June 2017, 90 cases of vaginal bleeding after drug abortion in the People's Hospital of Dongping County were divided into the observation group and the control group according to the digital table, with 45 cases in each group.The two groups were all treated with drug abortion to terminate pregnancy, and the control group was treated with metronidazole tablets + carbazochrome tablets after the termination of pregnancy.The observation group was treated with Huoxue Qing Gong decoction on the basis of the control group.The effect of abortion, bleeding time and bleeding volume after drug abortion, the time of menstrual recovery and menstrual duration after treatment in the two groups were observed and compared. Results The total abortion rate in the observation group was 95.6%, which was significantly higher than that in the control group(84.4%), the difference was statistically significant(χ2=5.620, P previous menstrual volume after drug abortion of the observation group was 17.8%, which was significantly lower than that of the control group(44.4%), the difference was statistically significant(χ2=6.375, P<0.05). The period of menstrual recovery of the observation group was (29.5±4.2)d, which was significantly shorter than that of the control group[(37.9±4.3)d](t=5.028, P<0.05). The duration of menstruation in the observation group was (5.0±1.1)d, which was significantly shorter than that in the control group[(6.9±1.2)d], the difference was statistically significant(t=3.229, P<0.05). Conclusion Huoxue Qing Gong decoction in the treatment of vaginal bleeding after drug abortion can significantly shorten the time of vaginal bleeding, reduce the amount of vaginal bleeding, improve the rate of complete abortion, and has no obvious effect on the first menstrual cycle and menstrual period after the drug flow. Key words: Abortion, induced/adverse effects; Uterine hemorrhage; Blood act stasis remov; Huoxue Qing Gong decoction; Abortion rate; Menstrual cycle; menstrual recovery; Termination of pregnancy

Professor Wei Gunzheng’s Experience in Treating COPD with Bu Fei Ping Chuan Decoction

Professor Wei Gunzheng; Bu Fei Ping Chuan decoction; COPD

Garbhini Paricharya in COVID-19 pandemic: A leading role of Ayurveda

Introduction: The coronavirus disease 2019 (COVID-19) is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome corona virus 2 (SARS COV-2) and Garbha-kala is one of the most crucial and responsible stage in woman's life. COVID-19 can produce devastating effect on maternal wellbeing. Garbhini Jwara can be interrelated to some extent with features of COVID-19 in pregnancy. Objective: As, there is still some time for the approval and distribution of anti-viral vaccine against it. Thus, imperative critical care is a pre-requisite to manage COVID-19 during pregnancy. Due to shortfall of data on COVID-19 in traditional system of knowledge, present trial utilizes treatment modalities mentioned in ayurvedic classics to conquer novel COVID-19 symptomatically. Data Source: The proposed review article draws the data from different ayurvedic texts, research papers and drudging efforts are made to gather the knowlegde of Garbhini Paricharya from contemporary science to fulfill the lacunas and thoroughly excel in it. Review Method: The symptoms of COVID-19 can be analogized with the features of Sannipata Jwara during pregnancy. It epitomizes as Janapada-dhamsa vikara and can be categorized into Bhutabhisanga Agantuga Vikara (External cause of microbes). Result and Conclusion: Ayurveda exhilarate intensive approach to cope-up with this unprecedented pandemic of COVID-19 during pregnancy. Decoction prepared from the ayurvedic drugs like Tulsi patra, Shirish twak, Guduchi kanda, Yastimadhu mool and Nimba patra acts as Daha-prashaman, Jantughna, Swashara, Kasahara, Krimighna, Jwarahara and Rasayana. It possess Anti-viral, Anti-bacterial, Anti-inflammatory, Anti-oxidant, Immuno-modulatory properties due to various chemical constituents.

Study on the attenuation mechanism of aristolochia manshuriensis compatibility with zingiberis rhizoma based on different methods of boiling and blending

Objective Comparison of effects of Zingiberis Rhizoma and Aristolochia manshuriensis on diuretic effect and acute renal injury in rats by combining two methods of co-decoction and mixed-decoction. The effects of in vitro observation on normal human renal tubular epithelial cells (HK-2) were observed. Methods The rats were randomly divided into five groups: blank group, positive control group, aristolochia manshuriensis group, combined decoction group and divided decoction group, 8 rats in each group. The water-loading rat model was established by intragastric administration of normal saline. The urine of rats was collected and the volumes of urine were measured for 24 hours after the corresponding drugs were given to each group. After 2 weeks of gavage of the corresponding drugs in each group, the serum BUN, SCr and urine UCr and PRO levels were measured by 7600P automatic biochemical analyzer, and renal histopathology were observed by HE staining. The HK-2 cells were cultured in vitro and divided into control group, Aristolochia manshuriensis group, mixed decoction group and sub-decoction group. After 24 hour intervention, the activity of cells was detected by CCK-8 method and the apoptosis was observed by Hoechst stain method. Results There was no significant difference in 24 hour urine output between the groups (P>0.05). Compared with Aristolochia manshuriensis group, the kidney coefficient (0.010 1 ± 0.005 8 vs. 0.013 3 ± 0.007 8), SCr (38.52 ± 0.58 μmol/L vs. 46.61 ± 0.72 μmol/L), BUN (8.55 ± 0.12 mmol/L vs. 10.21 ± 0.30 mmol/L), UCr (52.21 ± 0.89 μmol/L vs. 57.71 ± 0.67 μmol/L), PRO (29.89 ± 0.18 mg/L vs. 34.23 ± 6.05 mg/L) of combined decoction group significantly decreased (P<0.05). The survival rate of HK-2 cells (72.45% ± 3.70% vs. 55.92% ± 8.39%) in combined decoction group significantly increased (P<0.01), and the apoptosis rate (7.9% ± 2.6% vs. 31.6% ± 9.1%) significantly decreased (P<0.01). Conclusions The traditional co-decoction method of Aristolochia manshuriensis compatibility with Zingiberis Rhizoma can achieve a certain attenuation effect, and the mixed-decoction group can not achieve the attenuating effec. Key words: Caulis aristolochiae manshuriensis; Zingiberis rhizoma; Compatibility (TCD); Decoction preparing methods; Toxicity of Chinese medicine; Acute kidney injury; Rats

Clinical study of Huatan-Quzhuo decoction combined with western medicine routine therapy for the patients with carotid artery atherosclerotic plaque

Objective To investigate the effectiveness and safety of Huatan-Quzhuo decoction in combination with western medicine for the treatment of carotid atherosclerotic plaques. Methods A total of 194 patients with carotid atherosclerosis were selected were randomly divided into two groups, 97 in each group. The control group was treated with simvastatin. The observation group was treated with Huatan-Quzhuo decoction on the basis of the control group. The serum levels of interleukin-1 (IL-1), tumor necrosis factor α (TNF-α), malondialdehyde (MDA), and superoxide dismutase (SOD) were observed before and after treatment in the two groups. The Sod, IMT, number of plaques, number of vulnerable plaques and area of plaques, carotid artery intima-media thickness (IMT), number of plaques, number of vulnerable plaques, and area of plaques were detected. Results After treatment, the levels of TC, TG, and LDL-C in the observation group were significantly lower than those in the control group (t were 4.546, 6.712, 4.872, P<0.01). After treatment, the IMT (0.85 ± 0.11 mm vs. 1.08 ± 0.13 mm, t=13.302), number of plaques (0.74 ± 0.36 vs. 1.02 ± 0.42, t=4.985), number of vulnerable plaques (0.24 ± 0.25 vs. 0.41 ± 0.27, t=4.550), and plaque area (50.06 ± 9.73 mm2vs. 68.52 ± 11.24 mm2, t=12.230) in the observation group were significantly lower than those in the control group (P<0.01). The levels of IL-1, TNF-α and MDA in the observation group were significantly lower than the control group (t were 13.089, 4.769, 10.442, P<0.01). The level of SOD was observation group was significantly higher than the control group (t=11.636, P<0.01). Conclusions The combination of Huatan-Quzhuo decoction and western medicine in the treatment of carotid artery atherosclerosis can regulate the level of blood lipids, improve the degree of atherosclerosis, reduce the degree of inflammation and oxidative stress. Key words: Atherosclerosis; Huatan-Quzhuo decoction; Simvastatin; Syndrome of phlegm and blood stasis blocking collaterals

Study of Dahuang-Huanglian-Xiexin decoction combined with conventional western medicine in patients with type 2 diabetes

Objective To evaluate the effects of the classical prescriptions Dahuang-Huanglian-Xiexin decoction combined with conventional western medicine on the lipid metabolism disorder and changes of intestinal microflora in patients with type 2 diabetes mellitus (T2DM). Methods A total of 120 patients who met the inclusion criteria were divided into the two group according to the treatment order, with 60 patients in each group. Both groups were given conventional hypoglycemic therapy, the control group was given bifidobacteria lactobacillus triple viable tablets, and the treatment group was given Dahuang-Huanglian-Xiexin decoction on the basis of the control group. Both groups were treated with 14 days for one course and 4 courses in total. The number of gram-positive coccus (G+c), gram-negative coccus (G-c), gram-positive bacillus (G+b) and gram-negative bacillus (G-b) in each 500 bacteria were observed under oil microscope, and the cocci/bacillus ratio were calculated. The TC and TG were detected by oxidase method, and HDL and LDL were detected by automatic biochemical analyzer. The FPG, 2 hPG and HbA1c were detected by automatic biochemical analyzer. TCM symptom scores were calculated. Results After treatment, the abdominal distension, congestion discomfort, and constipation score were significantly lower than the control group (t values were 3.685, 3.551 and 3.708, respectively, all Ps<0.05); Serum TG, TC and LDL-c levels were significantly lower than the control group (t values were 3.602, 3.581 and 3.421, respectively, all Ps<0.05); HDL-c level was significantly higher than that of the control group (t=3.358, P=0.046); Serum FPG, 2 hPG and HbA1c levels were significantly lower than the control group (t values were 3.502, 3.271 and 3.708, respectively, all Ps<0.05). After treatment, the G-c (271.47/500 ± 22.63/500 vs. 266.81/500 ± 22.36/500, t=3.792), G+b (81.26/500 ± 6.52/500 vs. 73.19/500 ± 6.94/500, t=3.511), G-b (183.76/500 ± 16.19/500 vs. 164.37/500 ± 15.83/500, t=3.306) levels in the treatment group significantly higher than those in the control group (P<0.05). After treatment, both c/b levels was (0.65 ± 0.13 vs. 0.87 ± 0.21, t=3.325) decreased significantly (P<0.05). Conclusions Dahuang-Huanglian-Xiexin decoction combined with conventional western medicine can improve the clinical symptoms of T2DM patients, reduce blood glucose and lipid levels, and inhibit the body mass and improve insulin resistance by adjusting the structure of intestinal flora, increasing probiotics and reducing pathogenic bacteria. Key words: Diabetes mellitus, type 2; Lipid metabolism disorders; Intestinal microflora; Dahuang-Huanglian-Xiexin decoction; Therapies, investigational

Clinical study of TIP technique combined with acupuncture and oral administration of Chinese medicine on chronic insomnia with syndrome of heart-kidney imbalance

Objective To evaluate the efficacy of low resistance thought induction psychotherapy (TIP) technique combined with acupuncture and oral Chinese medicine in treating chronic insomnia elderly patients with syndrome of heart-kidney imbalance. Methods One hundred sixty-four chronic insomnia patients with syndrome of heart-kidney imbalance were randomly divided into four groups with 41 cases in each group. The control group was treated with family doctor contract, sleep health education and Tianwang-Buxin decoction as the basic treatment, the group A was treated with acupuncture and the basic treatment, the group B was treated with TIP technique and the basic treatment, the group C was treated with the combination of acupuncture and TIP on the basic treatment. After one month' treatment, scores of Pittsburgh sleep quality index (PSQI) were used to evaluate sleep quality, sleep efficiency, and the clinical efficacy. Results After treatment, scores of sleep time, sleep efficiency, sleep time, sleep disturbance, daytime function of the group A, B, and C were significantly lower than those in the control group (F value were 44.322, 92.808, 107.131, 79.467, 98.638 respectively, all Ps<0.001), and the group C were significantly lower than those of the test group A and B (P<0.01). Scores of upset, dizziness, tinnitus, hot flashes, and night sweats, hand foot and heart fever, forgetfulness, sores on the tongue and dry stool of the group A, B, and C were significantly lower than those of the control group (F value were 103.32, 135.91, 93.35, 77.61, 57.514, 92.283, 126.097, 53.217, respectively, all Ps<0.001), and the group C were significantly lower than those of the test group A and B (P<0.01). The total clinical efficacy of TCM syndrome and insomnia in group A,B and C was significantly higher than that in the control group (χ2=16.169, P<0.01), and the group C was significantly higher than the group A and B (χ2=8.504, P<0.01). The total clinical efficacy of sleep efficiency in group A, B and C was significantly higher than that in the control group (χ2=14.078, P<0.01), and the group C was significantly higher than the group A and B (χ2=8.856, P<0.01). Conclusions TIP technique combined with acupuncture and oral Chinese medicine can improve sleep quality of chronic insomnia elderly patients with syndrome of heart-kidney imbalance. Key words: Insomnia; Low resistance thought induction psychotherapy; Acupuncture therapy; Tianwang-Buxin decoction; Syndrome of disharmony between heart and kidney

Effect of modified Gualou-Guizhi decoction combined with hyperbaric oxygen on muscle tension and motor function in stroke patients with spastic hemiplegia

Objective To observe the effect of modified Gualou-Guizhi decoction combined with hyperbaric oxygen on muscle tension and motor function in stroke patients with spastic hemiplegia. Methods A total of 70 stroke patients with spastic hemiplegia met the inclusion criteria were randomly divided into the observation group and the control group, with 35 in each group. The control group was given the conventional treatment and hyperbaric oxygen treatment, while the observation group was treated with Gualou-Guizhi decoction on the basis of the control group. Lindmark scale was used to assess limb motor function, Fugl-Meyer Assessment Scale (FMA) was used to assess the degree of limb motor dysfunction, and Modified Ashworth Scale (MAS) was used to assess muscle tension. The root mean square (RMS) and frequency median (FM) of surface electromyography of quadriceps femoris were measured by automatic electromyography, and the clinical efficacy was evaluate. Results The total effective rate of the observation group was 91.4% (32/35), and the total effective rate of the control group was 71.4% (25/35). The total effective rate of the 2 groups was statistically significant (χ2=4.629, P=0.0314). After treatment, the scores of motor coordination ability and sensory function in the observation group were significantly higher than those in the control group (t value were 5.936, 5.182, all Ps<0.05), the FMA scores of upper and lower limbs were significantly higher than those in the control group (t value were 12.310, 11.996, all Ps<0.01), and the score of improved Ashworth muscle strength scale was significantly lower than that in the control group (t=5.083, P=0.031). After treatment, the EMG RMS (79.13 ± 7.02 vs. 68.45 ± 7.01 , t=5.697), FM (99.31 ± 9.65 Hz vs. 90.73 ± 9.49 Hz, t=5.382) of the observation group were significantly higher than those of the control group (P<0.05). Conclusions The application of Gualou-Guizhi decoction add and subtract combined with hyperbaric oxygen on muscle tension and motor function in stroke patients with spastic hemiplegia can improve the muscle strength of stroke hemiplegic patients and improve the motor dysfunction of the patients, which can help to promote the recovery of the movement function of the patientst. Key words: Stroke; Spasm; Hemiplegia; Muscle tonus; Dyskinesias; Gualou-Guizhi decoction; Medicinal bath lotions; Hyperbaric oxygenation

Clinical research of Lishi-Jianpi-Quyu decoction combined with conventional western medicine for the patients with oral lichen planus

Objective To evaluate the therapeutic effect of Lishi-Jianpi-Quyu decoction combined with conventional western medicine for the oral lichen planus (OLP). Methods A total of 80 OLP patients who met the inclusion criteria were divided into two groups by random number table method, 40 in each group. The control group was treated with conventional medicine, while the research group were treated with Lishi-Jianpi-Quyu decoction on the basis of control group. Two groups were treated for 4 weeks. The severity of oral mucosal lesions was assessed by REU scale, and oral discomfort was assessed by VAS scale. The serum tumor necrosis factor-α (TNF-α), IL-6 and IL-8 levels were detected by ELISA, peripheral blood CD3+, CD4+ levels were detected by flow cytometry, and the ratio of CD4+/CD8+ was calculatedand the clinical efficacy was evaluated. Results The effective rate of research group was 82.5% (33/40), while the control group was 62.50% (25/40), and the difference between two groups was statistically significant (χ2=9.031, P=0.003). After treatment, TNF-α (1.19 ± 0.28 μg/L vs. 3.59 ± 0.72 μg/L, t=19.807), IL-6 (11.14 ± 2.04 ng/L vs. 16.34 ± 3.20 ng/L, t=8.666), IL-8 (1.15 ± 0.61 ng/L vs. 2.04 ± 0.76 ng/L, t=5.776) of research group were significantly lower than the control group (P<0.01). The serum CD3+ (64.02% ± 5.16% vs. 58.07% ± 4.85%, t=5.314), CD4+ (41.26% ± 3.61% vs. 37.15% ± 3.04%, t=5.508), CD4+/CD8+ (1.60 ± 0.43 vs. 1.31 ± 0.40, t=3.668) of research group were significantly higher than those of the control group (P<0.01). After treatment, the REU score and VAS score in the research group were significantly lower than that in the control group (t=10.980, 11.146, P<0.01). Conclusions The Lishi-Jianpi-Quyu decoction combined with conventional western medicine can improve the clinical symptoms of OLP, reduce the level of serum inflammatory cytokines, and enhance the body's immunity and improve the curative effect. Key words: Lichen Planus, Oral; Lishi-Jianpi-Quyu decoction; Tumor necrosis factor-alpha; Interleukin; Immune reconstitution

The efficacy of modified Quyuan decoction in treating children upper airway cough symptom complex with syndrome of phlegm and heat accumulated in lung

Objective To investigate the efficacy of modified Quyuan decoction in the treatment of Children upper airway cough symptom complex with syndrome of phlegm and heat accumulated in lung. Methods Eighty-two Children with upper airway cough symptom complex who met the inclusion criteria were randomly divided into 2 groups with 41 in each group. In the control group, monteluster sodium chewing tablets were taken orally and budesonide suspension was inhaled. The observation group took modified Quyuan decoction on the basis of the control group. Both groups were treated continuously for 2 weeks and followed up for 6 months. The levels of interleukin (IL)-8 and IL-13 were detected by double-antibody-sandwich ELISA, and the symptoms and signs were scored before and after treatment, as well as the symptoms of phlegm, heat and stagnation of lung, cough and pharynx. The efficacy was evaluated and recurrence rate was recorded. Results The total effective rate 95.12% (39/41) in the observation group was obviously higher than 75.61% (31/41) in the control group (χ2=4.783, P=0.029). After treatment, the serum level of IL-8 (51.61 ± 5.94 ng/L vs. 71.25 ± 7.99 ng/L, t=12.631) and IL-13 (27.62 ± 3.20 ng/L vs. 34.91 ± 4.01 ng/L, t=9.099) in the observation group were significantly lower than those in the control group (P<0.01). After treatment, the scores of cough, nasal obstruction, runny nose, nasal itching, expectoration, sneezing, secretion of posterior pharyngeal wall and pharyngeal mucosa in the observation group were all significantly lower than those in the control group (t values were 7.762, 6.831, 6.217, 6.944, 6.408, 6.212, 7.268, 7.109, all Ps<0.01). The scores of cough, expectoration, blood in sputum, chest pain, dry mouth and fever were significantly lower than those of the control group (t values were 9.439, 6.831, 6.982, 10.115, 12.031 and 10.443, all Ps<0.01). Scores of daytime and nighttime cough symptoms were significantly lower than those of the control group (t values were 7.012, 7.241, respectively, all Ps<0.01). The scores of pharyngeal pain, pharyngeal dryness and pharyngeal foreign body sensation were significantly lower than those of the control group (t values were 6.003, 6.106, 6.318, respectively, all Ps<0.01). In the 6 months' follow-up observation, the recurrence rate was 17.7% (3/17) in the observation group and 53.9% (7/13) in the control group, and the difference between the two groups was statistically significant (χ2=4.344, P=0.037). Conclusions The modified Quyuan decoction combined with conventional western medicine can improve the symptoms and signs of upper airway cough symptom complex of children with syndrome of phlegm and heat accumulated in lung. Key words: Cough; Child; Upper airway cough syndrome; Syndrome of phlegm and heat accumulated in lung; Quyuan decoction; Interleukin